Keywords: Sanofi, Rib-X Pharma, Tesamorelin, Israel, Theratechnologies, Novel antibiotics, Lipodystrophy

Sanofi in-licenses novel antibiotics from Rib-X; files tesamorelin in Israel

Article | 06 July 2011

French drug major Sanofi (Euronext: SAN) has entered into an exclusive worldwide accord with privately-held USA-based Rib-X Pharmaceuticals for novel ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Sanofi

Theratechnologies

Rib-X Pharmaceuticals

Go to company listing

Related Drugs

tesamorelin

Go to drug listing